TGM2 and acute lymphoblastic leukemia: In T cell lymphoblastic lymphoma, a subtype of T-ALL characterized by the accumulation of T-blasts in lymph nodes [100], the modulation of IL-6/JAK/STAT3 by the siRNA inhibition of TG2 has been demonstrated.